Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Vector Type (Viral, Non-viral); By Approach (Gene Augmentation, Oncolytic Viral Therapy, Immunotherapy, Others); By Therapeutic Area; By Route of Administration; By Regions; Segment Forecast, 2020 - 2027

Report Scope

Gene Therapy Market, Therapeutic Area Outlook (Revenue - USD Million, 2016 – 2027)

• Autoimmune Disorders
• Cardiovascular Diseases
• Dermatological Disorders
• Genetic Disorders
• Hematological Disorders
• Metabolic Disorders
• Muscle-related Diseases
• Oncological Disorders
• Ophthalmic Diseases
• Others

Gene Therapy Market, Vector Type Outlook (Revenue - USD Million, 2016 – 2027)

• Viral vectors
  • Retroviral vectors
    • Gamma-retroviral vectors
    • Lentiviral vectors
  • Adeno-associated virus vectors
  • other viral vectors
• Non-viral Vectors
  • Oligonucleotides
  • Other non-viral vectors (plasmids and RNAi)

Gene Therapy Market, Approach Outlook (Revenue - USD Million, 2016 – 2027)

• Gene Augmentation
• Oncolytic Viral Therapy
• Immunotherapy
• Others

Gene Therapy Market, Route of Administration Outlook (Revenue - USD Million, 2016 – 2027)

• Intraarticular
• Intracerebellar
• Intradermal
• Intramuscular
• Intratumoral
• Intravenous
• Intravesical
• Intravitreal
• Subretinal
• Others

Gene Therapy Market, Regional Outlook (Revenue - USD Million, 2016 – 2027)

• North America
  • Therapeutic Area Outlook
    • Autoimmune Disorders
    • Cardiovascular Diseases
    • Dermatological Disorders
    • Genetic Disorders
    • Hematological Disorders
    • Metabolic Disorders
    • Muscle-related Diseases
    • Oncological Disorders
    • Ophthalmic Diseases
    • Others
  • Vector Type Outlook
    • Viral vectors
      • Retroviral vectors
        • Gamma-retroviral vectors
        • Lentiviral vectors
      • Adeno-associated virus vectors
      • other viral vectors
    • Non-viral Vectors
      • Oligonucleotides
      • Other non-viral vectors (plasmids and RNAi)
  • Approach Outlook
    • Gene Augmentation
    • Oncolytic Viral Therapy
    • Immunotherapy
    • Others
  • Route of Administration Outlook
    • Intraarticular
    • Intracerebellar
    • Intradermal
    • Intramuscular
    • Intratumoral
    • Intravenous
    • Intravesical
    • Intravitreal
    • Subretinal
    • Others
• Europe
  • Therapeutic Area Outlook
    • Autoimmune Disorders
    • Cardiovascular Diseases
    • Dermatological Disorders
    • Genetic Disorders
    • Hematological Disorders
    • Metabolic Disorders
    • Muscle-related Diseases
    • Oncological Disorders
    • Ophthalmic Diseases
    • Others
  • Vector Type Outlook
    • Viral vectors
      • Retroviral vectors
        • Gamma-retroviral vectors
        • Lentiviral vectors
      • Adeno-associated virus vectors
      • other viral vectors
    • Non-viral Vectors
      • Oligonucleotides
      • Other non-viral vectors (plasmids and RNAi)
  • Approach Outlook
    • Gene Augmentation
    • Oncolytic Viral Therapy
    • Immunotherapy
    • Others
  • Route of Administration Outlook
    • Intraarticular
    • Intracerebellar
    • Intradermal
    • Intramuscular
    • Intratumoral
    • Intravenous
    • Intravesical
    • Intravitreal
    • Subretinal
    • Others
• Asia Pacific
  • Therapeutic Area Outlook
    • Autoimmune Disorders
    • Cardiovascular Diseases
    • Dermatological Disorders
    • Genetic Disorders
    • Hematological Disorders
    • Metabolic Disorders
    • Muscle-related Diseases
    • Oncological Disorders
    • Ophthalmic Diseases
    • Others
  • Vector Type Outlook
    • Viral vectors
      • Retroviral vectors
        • Gamma-retroviral vectors
        • Lentiviral vectors
      • Adeno-associated virus vectors
      • other viral vectors
    • Non-viral Vectors
      • Oligonucleotides
      • Other non-viral vectors (plasmids and RNAi)
  • Approach Outlook
    • Gene Augmentation
    • Oncolytic Viral Therapy
    • Immunotherapy
    • Others
  • Route of Administration Outlook
    • Intraarticular
    • Intracerebellar
    • Intradermal
    • Intramuscular
    • Intratumoral
    • Intravenous
    • Intravesical
    • Intravitreal
    • Subretinal
    • Others
• Latin America
  • Therapeutic Area Outlook
    • Autoimmune Disorders
    • Cardiovascular Diseases
    • Dermatological Disorders
    • Genetic Disorders
    • Hematological Disorders
    • Metabolic Disorders
    • Muscle-related Diseases
    • Oncological Disorders
    • Ophthalmic Diseases
    • Others
  • Vector Type Outlook
    • Viral vectors
      • Retroviral vectors
        • Gamma-retroviral vectors
        • Lentiviral vectors
      • Adeno-associated virus vectors
      • other viral vectors
    • Non-viral Vectors
      • Oligonucleotides
      • Other non-viral vectors (plasmids and RNAi)
  • Approach Outlook
    • Gene Augmentation
    • Oncolytic Viral Therapy
    • Immunotherapy
    • Others
  • Route of Administration Outlook
    • Intraarticular
    • Intracerebellar
    • Intradermal
    • Intramuscular
    • Intratumoral
    • Intravenous
    • Intravesical
    • Intravitreal
    • Subretinal
    • Others
• Middle East & Africa
  • Therapeutic Area Outlook
    • Autoimmune Disorders
    • Cardiovascular Diseases
    • Dermatological Disorders
    • Genetic Disorders
    • Hematological Disorders
    • Metabolic Disorders
    • Muscle-related Diseases
    • Oncological Disorders
    • Ophthalmic Diseases
    • Others
  • Vector Type Outlook
    • Viral vectors
      • Retroviral vectors
        • Gamma-retroviral vectors
        • Lentiviral vectors
      • Adeno-associated virus vectors
      • other viral vectors
    • Non-viral Vectors
      • Oligonucleotides
      • Other non-viral vectors (plasmids and RNAi)
  • Approach Outlook
    • Gene Augmentation
    • Oncolytic Viral Therapy
    • Immunotherapy
    • Others
  • Route of Administration Outlook
    • Intraarticular
    • Intracerebellar
    • Intradermal
    • Intramuscular
    • Intratumoral
    • Intravenous
    • Intravesical
    • Intravitreal
    • Subretinal
    • Others

Qualitative Analysis

• Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
• Competitive landscape
  • Overview
  • Financials
  • Product benchmarking
  • Latest strategic developments
  • Price Trend Analysis

Quantitative Analysis

• Market size, estimates, and forecasts from 2020 - 2027
• Market size and revenue estimates for application up to 2027
• Market revenue estimates for type up to 2027
• Market revenue estimates for end-use up to 2027
• Regional market size and forecast up to 2027
• Company financials